|Application Due Date Approaching|
|Research award applications are due October 15, 2019. Request your Dropbox link today. Applicant information is found here.|
|Reserve your space in the 2020 DF Clinical Symposia. February 5-9 in Naples, FL.|
|New Opportunity for Mid-Career Investigators|
|DF and MRA are co-sponsors of a new award for melanoma detection or prevention, effective July 1, 2020. More information here.|
|NEW in 2020: Women's Health Research Grant|
|A new research grant is now available for research focusing on women's health issues. More details are found here.|
|2019 DF Research Award Recipients|
|Congratulations to the 2019 DF Research Awardees.|
The Dermatology Foundation
Established in 1964, the Foundation is a 501(c)3 charitable organization dedicated to enabling advancements in patient care. The DF accomplishes this important work by providing research funding each year to promising early and mid-career investigators whose novel ideas have the potential to shape the future of the specialty.
Thanks to its many physician members and industry constituents over more than five decades, the DF funding has had a tremendous long-term effect on the specialty. Foundation support has helped to:
- Deepen our understanding of diseases and conditions including psoriasis, atopic dermatitis, inflammatory dermatoses, and autoimmune skin diseases.
- Develop innovations including topical therapies for skin cancer, outcomes research, and biologic therapies.
- Keep talented researchers working in our field by supporting their work at critical points where private funding is the key to their continued success.
With the continued support of dermatologists, specialty societies and corporate supporters, the DF can continue to further progress in all areas of the specialty, for the benefit of patients everywhere.
DF Stiefel Scholar Awardee Makes Big Strides in Addressing Vitiligo
John E. Harris, MD, PhD, Associate Professor at the University of Massachusetts, is on the verge of radically transforming care for patients suffering with vitiligo, a common and disfiguring autoimmune disease with (as yet) no FDA-approved medical treatments. He has progressed rapidly in advancing knowledge of the autoimmune pathways that cause this disease and now is closing in on a treatment goal that has remained unmet—skin that remains normal after treatment is stopped.
Survey Underscores High Impact of DF Funding
The DF's highly-competitive career development award (CDA) has launched the investigative work and careers of many researchers since it was introduced in 1990. A recent article in the Journal of the American Academy of Dermatology shares the results of a survey of CDA recipients undertaken to measure the effectiveness of this funding mechanism—and the results confirm the importance of Foundation support.
The DF's investment in CDAs over the last three decades has benefitted the entire specialty—it has supported innovations that have led to improved patient care, enabled recipients to secure more than $10 in federal funding for every dollar they received from the DF, and has helped to develop and retain an academic workforce.
Read the details.
Founded in 1964
|Janet A. Fairley, M.D.|
|Bruce U. Wintroub, M.D.|
Chairman, Board of Trustees
|Stuart R. Lessin, M.D.|
|Elizabeth I. McBurney, M.D.|
|Members at Large:|
| Yvonne E. Chiu, M.D.|
George Cotsarelis, M.D.
Sewon Kang, M.D.
Renée J. Mathur, M.D.
Kishwer S. Nehal, M.D.
Seth J. Orlow, M.D., Ph.D.
John T. Seykora, M.D., Ph.D.
Michael D. Tharp, M.D.
Jonathan S. Weiss, M.D.
|Sandra Rahn Benz |
|Christine M. Boris |
Deputy Executive Director
|1560 Sherman Avenue|
Evanston, IL 60201-4808
Phone: (847) 328-2256
Fax: (847) 328-0509
Send an e-mail.